Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Grammy nominations 2026: Full list of nominees in every major category, including Album of the Year and Best New Artist- New Gaza militia declares war on Hamas: 'Your dirty shoes are more honorable'
- 'All Her Fault' ending explained: The shocking conclusion to the psychological thriller inspired by true events
- January full moon wows skywatchers with a striking 'Wolf Supermoon' (photos)
- From Fledgling to Master: Self-awareness in a Side interest
- New movies to watch this week: See 'Marty Supreme' in theaters, rent 'Springsteen: Deliver Me from Nowhere,' stream 'Cover-Up' on Netflix
- 'Stranger Things' series finale trailer shows Hawkins gang gearing up for last battle with Vecna
- Michael Jordan donates $10M to North Carolina medical center in honor of his mother
- Somaliland denies trading recognition with Israel for accepting Gazans
